In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis

References

• Ahsan F, Rivas IP, Khan MA, Torres SA. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres on the phagocytosis by macrophages. J Control Release, 79(1-3), 29–40.
   PubMed Web of Science ®Google Scholar
• Barratt GM, Nolibe D, Yapo A, Petit JF, Tenu JP. (1987). Use of mannosylated liposomes for in vivo targeting of a macrophages activator and control of artificial pulmonary metastases. Ann Instit Past Imm, 138, 437–443.
   PubMedGoogle Scholar
• Basu MK, Lala S. (2004). Macrophages specific drug delivery in experimental leishmaniasis. Curr Mol Med, 4(6), 681–689.
   PubMed Web of Science ®Google Scholar
• Cao T, Wang A, Liang X, Tang H, Auner GW, Salley SO, Ng KY. (2007). Investigation of spacer length effect on immobilized Escherichia coli pili-antibody molecular recognition by AFM. Biotechnol Bioeng, 98(6), 1109–1122.
   PubMed Web of Science ®Google Scholar
• Carter KC, Dolan TF, Alexander J, Baillie AJ, McColgan C. (1989). Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice. J Pharm Pharmacol, 41(2), 87–91.
   PubMed Web of Science ®Google Scholar
• Chakraborty P, Bhaduri AN, Das PK. (1990). Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis. Biochem Biophys Res Commun, 166, 404–411.
   PubMed Web of Science ®Google Scholar
• Chellat F, Merhi Y, Moreau A, Yahia LH. (2005). Therapeutic potential of nanoparticulate systems for macrophages targeting. Biomaterial, 26, 7260–7275.
   PubMed Web of Science ®Google Scholar
• Coester CJ, Langer K, Van Briesen H, Kreuter J. (2000). Gelatin nanoparticles by two-step desolvation-a new preparation method, surface modifications and cell uptake. J Microencapsul, 17, 187–193.
   PubMed Web of Science ®Google Scholar
• Copland MJ, Baird MA, Rades T, McKenzie JL, Becker B, Reck F, Tyler PC, Davies NM. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine, 21, 883–890.
   PubMed Web of Science ®Google Scholar
• Dube A, Singh N, Sundar S, Singh N. (2005). Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persists in in vitro and in vivo experimental models. Parasitol Res, 96, 216–223.
   PubMed Web of Science ®Google Scholar
• Dutta T, Jain NK. (2007). Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochem Biophys Acta, 1770, 681–686.
   PubMed Web of Science ®Google Scholar
• Echevarria I, Barturen C, Renedo MJ, Dios-Vieitez MC. (1998). High-performance liquid chromatographic determination of amphotericin B in plasma and tissue; application to pharmacokinetic and tissue distribution studies in rats. J Chromatogr A, 819, 171–176.
   PubMed Web of Science ®Google Scholar
• Garcon N, Gregoriadis G, Taylor M, Summerfield J. (1988). Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology, 64, 743–749.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mejia ME, Doseff AI. (2009, January 1). Regulation of monocytes and macrophages cell fate. Front Biosci, 14, 2413–2431.
   Web of Science ®Google Scholar
• Guru PY, Agarwal AK, Singhal UK, Singhal A, Gupta CM. (1989). Drug targeting in Leishmania donovani infections using tuftsin bearing liposomes as drug vehicles. FEBS Lett, 245, 204–208.
   PubMed Web of Science ®Google Scholar
• Huth US, Schubert R, Peschka-Suss R. (2006). Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J Control Rel, 110(3), 490–504.
   PubMed Web of Science ®Google Scholar
• Jahromi HS, Taghdisian H, Afshar S, Tasharrofi S. (2009). Effects of pH and polyethylene glycol on surface morphology of TiO2 thin film. Surf Coat Tech, 203(14), 1991–1996.
   Web of Science ®Google Scholar
• Jahanshahi M, Babaei Z. (2008). Protein nanoparticle: A unique system as drug delivery vehicles. African J Biotechnology, 7(25), 4926–4934.
   Web of Science ®Google Scholar
• Kassab R, Parrot-Lopez H, Fessi H, Menaucourt J, Bonaly R, Coulon J. (2002). Molecular recognition by kluyveromyces of amphotericin B-loaded, galactose-tagged, poly (lactic acid) microspheres. Bio Org Med Chem, 10:1767–1775.
   PubMed Web of Science ®Google Scholar
• Kleinberg M. (2006). What is the current and future status of conventional amphotericin B? Int J Antimicrob Agents, 27S, S12–S16.
   Web of Science ®Google Scholar
• Leo E, Cameroni R, Forni F. (1999). Dynamic dialysis for the drug release evaluation from doxorubicin–gelatin nanoparticles conjugates. Int J Pharm, 180, 23–30.
   PubMed Web of Science ®Google Scholar
• Lu Z, Yeh TK, Tsai M, Au JLS, Wientjes MG. (2004). Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res, 10, 7677–7684.
   PubMed Web of Science ®Google Scholar
• Mckinney R, Thacker L, Hebert GA. (1976). Conjugation methods in immunofluorescence. J Dent Res, 55, A38–A43.
   PubMed Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dubey V, Dabadghao S, Jain NK. (2007). Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes. Vaccine, 25, 6939–6944.
   PubMed Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK. (2008). Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen loaded modified liposomes. Eur J Pharm Sci, 33, 424–433.
   PubMed Web of Science ®Google Scholar
• Mitchell JP, Roberts DR, Langley J, Koentgen F, Lambert JN. (1999). A direct method for the formation of peptide and carbohydrate dendrimers. Bio Org Med Chem Lett, 9, 2785–2788.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Rajabi-Siahboomi AR. (1996). Advanced colloids based system for efficient delivery of drugs and diagnostics agents to lymphatic tissue. Progress Biophy Mole Bio, 65(3), 221–249.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev, 53(2), 283–318.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay A, Basu SK. (2003). Intracellular delivery of drugs to macrophages. Adv Biochem Eng/Biotech, 84, 183–209.
   PubMedGoogle Scholar
• Muller CD, Schuber F. (1989). Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages. Biochem Biophy Acta, 986, 97–101.
   PubMed Web of Science ®Google Scholar
• Nahar M, Dutta T, Murugesan S, Asthana A, Mishra D, Rajkumar V, Tare M, Saraf S, Jain NK. (2006). Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit Rev Ther Drug Carrier Syst, 23, 259–318.
   PubMed Web of Science ®Google Scholar
• Nahar M, Mishra D, Dubey V, Jain NK. (2008). Development, characterization and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed: Nanotech Bio Med, 4, 252–261.
   PubMed Web of Science ®Google Scholar
• Owais M, Gupta, CM. (2005). Targeted drug delivery to macrophages in parasitic infections. Curr Drug Deliv, 2(4), 311–318.
   PubMedGoogle Scholar
• Saxena A, Sachin K, Bohidar HB, Verma AK. (2005). Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nano-particles. Coll Surf B: Biointerfaces, 45, 42–48.
   PubMed Web of Science ®Google Scholar
• Sett R, Sarkar K, Das PK. (1993). Macrophages-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease. J Infect Dis, 168(4), 994–999.
   PubMed Web of Science ®Google Scholar
• Venier-Julienne M, Benoit J. (1996). Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Pharm Acta Helv, 71, 121–128.
   PubMedGoogle Scholar
• Yamashita C, Sone S, Ogura T, Kiwada H. (1991). Potential value of cetylmannoside-modified liposomes as carriers of macrophages activators to human blood monocytes. Japan J Cancer Res, 82, 569–575.
   PubMedGoogle Scholar
• Zillies J, Coester C. (2005). Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides. J Pharm Pharm Sci, 7(4), 17–21.
   PubMedGoogle Scholar
• Zillies JC, Zwiorek K, Hoffmann F, Vollmar A, Anchordoquy TJ, Winter G, Coester C. (2008). Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles. Eur J Pharm Biopharm, 70(2), 14–521.
   Web of Science ®Google Scholar